Results 181 to 190 of about 554,589 (315)
Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light
Medicinal Research Reviews, EarlyView.ABSTRACT Dopaminergic neurotransmission is involved in several important brain functions, such as motor control, learning, reward‐motivated behavior, and emotions. Dysfunctions of dopaminergic system may lead to the development of various neurological and psychiatric disorders, like Parkinson's disease, schizophrenia, depression, and addictions ...
Galyna Maleeva +5 more
wiley +1 more source
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome. [PDF]
Sleep, 2022 Winkelman JW.
europepmc +1 more source
Dopamine-Deficient Mice Are Hypersensitive to Dopamine Receptor Agonists [PDF]
, 2000 Douglas S. Kim +2 more
openalex +1 more source
Dopamine agonist responsive burning mouth syndrome: Report of eight cases. [PDF]
World J Clin Cases, 2021 Du QC, Ge YY, Xiao WL, Wang WF.
europepmc +1 more source
Reinforcing properties of Pramipexole in normal and parkinsonian rats
Neurobiology of Disease, 2013 Striatal D2 and D3 dopamine receptors are involved in mediating the reinforcing properties of natural rewards and drugs. In Parkinson's disease, while D2/3 dopamine agonists alleviate motor symptoms, behavioral addictions and withdrawal syndrome are ...
Michel Engeln +5 more
doaj
Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial [PDF]
, 2000 James A. Tumlin +9 more
openalex +1 more source
Recent Advances in Mammalian Olfactory Receptor Function and Structure
Sensory Neuroscience, EarlyView.Olfactory receptors (ORs), a subset of G protein‐coupled receptors (GPCRs), mediate odor detection in sensory neurons and regulate diverse physiological functions across tissues. Their roles in metabolism, immunity, and neural processes underscore their therapeutic relevance. Recent high‐resolution Cryo‐EM studies have unveiled OR activation mechanisms,
Hongxi Qin +9 more
wiley +1 more source
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? [PDF]
Endocr Oncol, 2022 De Sousa SMC.
europepmc +1 more source
Journal of Pharmacological Sciences, 2003 : κ-Opioid receptor agonists decrease the levels of extracellular dopamine in vivo and in vitro. However, the mechanism(s) underlying these actions are unclear.
Nuannoi Chudapongse +3 more
doaj